Seeking Alpha
View as an RSS Feed

Shlomo Wiesen  

View Shlomo Wiesen's Comments BY TICKER:
Latest comments  |  Highest rated
  • Will Patent Office Eliminate Vringo's Right To Future Royalties From Google? [View article]
    Daniel, with all due respect, many here believe that you are the 'irrational' person you speak of, based on your own words.

    "The future royalty hope and hype is similarly, in my opinion, extremely overstated by emotional irrational longs."

    Writing 'hope and hype' is misleading. Vringo was awarded future damages, were they not? Why is that hope and hype?

    And how about this whopper:

    "bogus patents being used to take money that's undeserved"

    Do you give no credit at all to Ken Lang? A man fights back for what he believes is his. What is bogus about that?

    I have no issue with your being short, as I pointed out in my balanced Vringo article.

    But to say that you, executive director of the Public Patent Foundation which had revenues of $530,000 last year, and to which you received $90,000 in salary, to say that you are not biased against Vringo would be, in your own words, irrational.
    Dec 13, 2012. 12:33 PM | 12 Likes Like |Link to Comment
  • The Judge Should Rule Favorably For Vringo On Motions [View article]
    Lol! Well isn't it great to have good citizens like Ravicher who walk the streets, looking to protect and warn Vringo investors such as myself?!

    I hope Ravicher hasn't invested his non-profit's grant money into shorting Vringo.......that money will burst into flames....
    Dec 19, 2012. 01:14 AM | 7 Likes Like |Link to Comment
  • Will Patent Office Eliminate Vringo's Right To Future Royalties From Google? [View article]
    I am glad that Dan brought up the SEC, and it brings to mind a quick question that I have, as I am unfamiliar with the peculiarities regarding the SEC's probes.

    Can the SEC investigate a non-profit organization whose CEO is privately making money off of companies that his own organization is targeting?

    Would seem to make sense, no?
    Dec 13, 2012. 01:33 PM | 6 Likes Like |Link to Comment
  • Why You Should Short Vringo Above $4 [View article]
    Also, if Vringo wins against ZTE, then Nokia profits big time. And since you own NOK, you will indirectly profit off of VRNG's success (a company you despise), though your VRNG short position will sink you. GL
    Nov 20, 2012. 06:49 AM | 6 Likes Like |Link to Comment
  • Thoughts On Vringo's Response In Support Of Its Motion For Ongoing Royalties [View article]
    great article, lets hope youre right
    May 24, 2013. 11:42 AM | 5 Likes Like |Link to Comment
  • Why You Should Short Vringo Above $4 [View article]
    I'm okay with the secondary offerings. $60 million in the bank is crucial while negotiating. As an investor, I agree with dilution. Not anymore though, and, if we can believe them, there won't be anymore for a while.
    Nov 20, 2012. 08:11 AM | 5 Likes Like |Link to Comment
  • Shares Of Vringo Are Becoming A Long-Term Investment For Investors: Why It Might Not Be A Bad Thing After All [View article]
    Justin I've enjoyed your writing, but I didn't agree at all with the tone of your buyout talk. If we learned anything from last year's battle, Google has no interest in settling let alone a buyout.

    "Instead of shelling out hundreds of millions of dollars, Google should simply buy Vringo. Google is on track to bring in close to $60 billion in revenue this year. I'm sure half a billion wouldn't make that big of a dent in their pocket books."

    I really hate that type of logic when it comes to David vs Goliath lawsuits. They don't just acquire companies wily nily because they don't make big dents in their pockets. If so, then you could argue that Apple should even more so buyout Vringo, because they have $100 billion in the bank, (and could certainly utilize Vringo's patents). But more acutely, do you really think Vringo would agree to be bought out for $500 million right now? With all of the appetizing lawsuits that you outlined above? And with the looming multi-hundred million payout that they are expecting from Google soon? I'd say right now, with Vringo in the drivers seat, a buyout would cost over a billion, maybe 1.5 billion, and that is certainly a dent in a pocket.
    Nov 11, 2013. 12:38 PM | 4 Likes Like |Link to Comment
  • Vringo's Billion-Dollar Win At Hand [View article]
    The stock already went to down to 2. And the "pyrrhic victory" against Google was priced in when VRNG dropped after the win, and the case can only get better for Vringo at this point (in all likelihood)
    Apr 7, 2013. 12:34 PM | 4 Likes Like |Link to Comment
  • Vringo Vs. Google: An Analysis Of The USPTO Re-Examination Debate [View article]
    Great article by Georgi, and about time someone exposed Dan's laughably faulty arguments. Amazing that someone whose salary comes from a 'non-profit' is allowed to invest in stocks that his government money-assisted organization is targetting, and walk the streets freely.

    And the gall of Dan to suggest that Vringo should be probed by the SEC. Dan and his patent 'non profit' should be audited immediately.
    Dec 15, 2012. 10:40 AM | 4 Likes Like |Link to Comment
  • Vringo Verdict And Future Royalties Against Google On Shaky Ground [View article]
    Agreed. The constant references to the (paltry) $31 mil amount was transparently misleading.
    Dec 5, 2012. 10:33 AM | 4 Likes Like |Link to Comment
  • Vringo: The Fallacy Of Impatience [View article]
    In 9th grade, I struggled with reading comprehension, so the teacher gave me a list of 10 books to read, in an effort to sharpen my reading comp skills. From what I recall, the books consisted of Dickens, Shakespeare, and Sinclair Lewis. They were hard books at the time, but they helped me appreciate and understand texts and their implications.

    For you to deduce that impatient Vringo investors will sell after 'it turns out the jury didn't make a math error' means you ought to read a few classics. The impatient investors already sold and their opportunity to get back in is closing. For shorts such as yourself, I preach patience and confidence. You may not have it now, but when you go back and read some Shakespeare, you can then read my article once more, and then let's talk again.
    Nov 16, 2012. 04:31 AM | 4 Likes Like |Link to Comment
  • Does Vringo Have A Plan Beyond Google? [View article]
    Agreed- as i stated in my prior vringo article, their r&d is what they need to ultimately develop a real business. I think vringo has plenty of patents to utilize, and WDDD looks like a mess right now that vringo cant afford to wade into.
    Sep 19, 2013. 12:37 PM | 3 Likes Like |Link to Comment
  • Generex: Research For Sale On The Cheap [View article]
    If you read the actual words in the article (all of them) you would see that this is far from a pump. If anything, Barnard's frankness had me hesitate a bit over my shares.

    "Bet only your casino money on this one because you'll probably leave it at the tables."

    Not a pump at all.
    Mar 15, 2013. 07:02 AM | 3 Likes Like |Link to Comment
  • Google's Wide Moat Widens Every Second [View article]
    Thanks for mentioning my article. I don't necessarily disagree that Google is a major player and that their personalized style of search is attractive to you and others. But that same notion, 'personalization' is what scares people away (NSA, Prism) into maybe trying DuckDuckGo or other alternatives.
    Feb 27, 2014. 05:41 AM | 2 Likes Like |Link to Comment
  • A Brand New Chapter And New Opportunities In The Wicked Story Of Cel-Sci Corporation? [View article]
    The survival of CVM is relying on Multikine, everyone knows that. With more and more dilution, Cel Sci is clinging to hope. Geert Kersten does not give me much confidence in the business side of things. He has a handsome salary, and gives me pause about buying CVM stock. As an investor, however, I wonder if it really matters if CVM gets delisted. If hits the pink sheets and subsequently drops a bit more, I would consider jumping in at 50 cents, only because CVM is shaping up to be the only penny stock that has a reasonably legitimate drug in phase III testing. Far from a guarantee, but favorable Multikine news would push this stock to anywhere from 200 to 2000 percent higher. And bad news might make it drop 50%. That's why, despite my dislike of Kersten, and maybe a 15-25% chance of success, I'm probably going to buy if it dips into the .50's.
    Oct 11, 2013. 09:47 AM | 2 Likes Like |Link to Comment